Evidence map›Paper›PMID 17268929›Full record

ArticleQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation2007

Health-related quality of life in HIV-1-infected patients on HAART: a five-years longitudinal analysis accounting for dropout in the APROCO-COPILOTE cohort (ANRS CO-8).

Camelia Protopopescu, Fabienne Marcellin, Bruno Spire, Marie Préau, Renaud Verdon, Dominique Peyramond, François Raffi, Geneviève Chêne, Catherine Leport, Maria-Patrizia Carrieri

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Health-related quality of life and its predictors among adults living with HIV/AIDS and receiving antiretroviral therapy in Pakistan.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2021
    Article
  12. Review
  13. Predictors of health-related quality of life among military HIV-infected individuals.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2020
    Article
  14. Article
  15. Article
  16. Changes and determinants of health-related quality of life among people newly diagnosed with HIV in China: a 1-year follow-up study.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2019
    Article
  17. Article
  18. Article
  19. Article
  20. Impact of hepatitis B and C co-infection on health-related quality of life in HIV positive individuals.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Camelia ProtopopescuHealth and Medical Research National Institute (INSERM), Research Unit 379, Social Sciences Applied to Medical Innovation, 23, rue Stanislas Torrents, 13006, Marseilles, France.
Fabienne Marcellin
Bruno Spire
Marie Préau
Renaud Verdon
Dominique Peyramond
François Raffi
Geneviève Chêne
Catherine Leport
Maria-Patrizia Carrieri

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe long-term efficacy of Highly Active Antiretroviral Therapies (HAART) has enlightened the crucial role of health-related quality of life (HRQL) among HIV-infected patients. However, any analysis of such extensive longitudinal data necessitates a suitable handling of dropout which may correlate with patients' health status.

methodsWe analysed the HRQL evolution over 5 years for 1,000 patients initiating a protease inhibitor (PI)-containing therapy, using MOS SF-36 physical (PCS) and mental (MCS) scores. In parallel with a classical separate random effects model, we used a joint parameter-dependent selection model to account for non-ignorable dropout.

resultsHRQL evolved according to a two-phase pattern, characterized by an initial improvement during the year following HAART initiation and a relative stabilization thereafter. Immunodepression and self-reported side effects were found to be negative predictors of both PCS and MCS scores. Hepatitis C virus coinfection and AIDS clinical stage were found to affect physical HRQL. Results were not significantly altered when accounting for dropout.

conclusionSuch results, obtained on a large sample of HIV-infected patients with extensive follow-up, underline the need for a regular monitoring of patients' immunological status and for a better management of their experience with hepatitis C and HAART.

Indexed as

Antiretroviral Therapy, Highly ActiveQuality of LifeSickness Impact ProfileTreatment OutcomeAdultFemaleFranceHealth StatusHepatitis CHIV-1HIV InfectionsHumansLongitudinal StudiesMaleModels, StatisticalOutcome Assessment, Health CareProtease Inhibitors

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.